The effect of high glucose on NO and O2- through endothelial GTPCH1 and NADPH oxidase

Life Sci. 2004 Nov 12;75(26):3185-94. doi: 10.1016/j.lfs.2004.06.005.

Abstract

Although endothelial dysfunction deteriorates diabetic angiopathy, the mechanisms are obscure. We revealed that high glucose augmented eNOS through stimulation of eNOS mRNA in cultured BAECs. NO was decreased and O2- was increased simultaneously. NOS inhibitor, inhibited O2- release, so did NADPH oxidase inhibitor. The effects were synergistic. Both intracellular BH4 level and GTPCH1 activity were decreased by high glucose, in line with decrease of GTPCH1 mRNA. HMG-CoA reductase inhibitor, atorvastatin increased GTPCH1 mRNA and activity, and BH4 level. Conclusively, high glucose leads to eNOS dysfunction by inhibiting BH4 synthesis and atorvastatin stimulate BH4 synthesis directly, and it may work as atherogenic process.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Atorvastatin
  • Biopterins / analogs & derivatives*
  • Biopterins / metabolism
  • Blotting, Western
  • Cattle
  • Endothelial Cells / drug effects*
  • Flow Cytometry
  • GTP Cyclohydrolase / metabolism
  • Gene Expression Regulation, Enzymologic / drug effects*
  • Glucose / pharmacology*
  • Heptanoic Acids / pharmacology
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology
  • NADPH Oxidases / antagonists & inhibitors
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase / metabolism*
  • Nitric Oxide Synthase Type III
  • Oxygen / metabolism
  • Pyrroles / pharmacology
  • RNA, Messenger / metabolism*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Statistics, Nonparametric

Substances

  • Heptanoic Acids
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pyrroles
  • RNA, Messenger
  • Biopterins
  • Nitric Oxide
  • Atorvastatin
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type III
  • NADPH Oxidases
  • GTP Cyclohydrolase
  • sapropterin
  • Glucose
  • Oxygen